Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Price Is Right: Amgen Defends Repatha At $9,669 Against More Critics

Aug 23 2017

• By Emily Hayes

Cholesterol plaque in artery

Related Content

Amgen's Repatha Contract With Harvard Pilgrim Includes A Full Refund

May 03 2017

Is Amgen's FOURIER Enough For Physicians, Payers To Expand Repatha Use?

Mar 18 2017

Amgen Beats Consensus, Raises Earnings Guidance, But Is It Sustainable?

Jul 26 2017

Related Companies

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Merck & Co., Inc.

Additional Topics

Pricing Strategies Cost Effectiveness Reimbursement Market Access Commercial Cardiovascular BioPharmaceutical

More from Drug Pricing

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window